Home > Gastroenterology > UEGW 2021 > Endoscopy > Motorised spiral enteroscopy safe in real-life and in patients with altered anatomy

Motorised spiral enteroscopy safe in real-life and in patients with altered anatomy

Presented by
Dr Torsten Beyna, Evangelic Hospital Düsseldorf, Germany
Conference
UEGW 2021
Trial
SAMISEN
In a real-life setting, motorised spiral enteroscopy (MSE) was safe and effective to use in a large cohort of patients. Moreover, safety and feasibility of this procedure was demonstrated for the first time in post-surgical patients and patients with altered anatomy. These were the main outcomes of the prospective multicentre SAMISEN trial.

Two trials have shown the safety and efficacy of MSE for antegrade and total enteroscopy respectively [1,2]. The use of MSE in real-life settings outside MSE-expert centres and safety and effectiveness of MSE in post-surgical patients and patients with altered anatomy had not yet been investigated. The SAMISEN trial (NCT03955081) enrolled 10 European centres with a variety of MSE experience [3]. For the core analysis, 251 patients were included, and 47 patients were allocated to the training phase for novel MSE users. Primary endpoint was a non-inferior safety profile of the procedure, defined as a serious adverse event (SAE) rate <8%. Dr Torsten Beyna (Evangelic Hospital Düsseldorf, Germany) presented the results.

MSE demonstrated favourable safety outcomes. The overall SAE rate was 2.3% (95% CI 0.9-4.8). The core phase had an SAE rate of 2.0% and the training phase had an SAE rate of 4.3%. The SAEs included a perforation and a deep mucosal laceration of the oesophagus. Subgroup analysis showed that within the postsurgical/altered anatomy subgroup the SAE rate was 1.9%, representing only 1 case out of 53 participants. In 9.6% of the patients AEs occurred, mostly related to clinically asymptomatic mucosal lacerations at the level of the oesophagus, the cardia, and the small bowel. The anatomic region of interest was reached in 88% of the performed procedures, total enteroscopy was successful in >50% of the patients that were planned for this procedure (n=81). The diagnostic yield of MSE was 83% and the therapeutic yield was 60.2% in this study.

  1. Beyna T, et al. Gut. 2021; 70(2):261-267
  2. Beyna T, et al. Gastrointest Endosc. 2021;93(6):1362-1370
  3. Beyna T, et al. Motorized spiral enteroscopy: results on an international multicenter, prospective clinical trial (samisen) including patients with postsurgical/altered anatomy. LB03, UEG Week 2021 Virtual Congress, 03–05 October.

 

Copyright ©2021 Medicom Medical Publishers

 



Posted on